Detalles de la búsqueda
1.
Efficacy of downtitration or treatment withdrawal compared with continuous dosing after successful treatment with baricitinib in patients with moderate-to-severe atopic dermatitis in a randomized substudy from the long-term extension study BREEZE-AD3.
Br J Dermatol;
188(2): 208-217, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36763879
2.
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7.
J Eur Acad Dermatol Venereol;
37(5): 1036-1045, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36514996
3.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
N Engl J Med;
374(13): 1243-52, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028914
4.
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.
Nephrol Dial Transplant;
33(11): 1950-1959, 2018 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481660
5.
Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials.
J Dermatolog Treat;
34(1): 2161812, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546346
6.
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials.
JAMA Dermatol;
157(6): 691-699, 2021 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978711
7.
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical Trials.
Am J Clin Dermatol;
22(3): 395-405, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826132
8.
Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis.
Arthritis Res Ther;
22(1): 115, 2020 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32414425
9.
Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis.
Arthritis Res Ther;
22(1): 166, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32616069
10.
Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment.
J Rheumatol;
46(1): 7-18, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30219772
11.
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trial.
Circ Cardiovasc Interv;
6(5): 567-74, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24065443
Resultados
1 -
11
de 11
1
Próxima >
>>